<!– –>
Covid-19, a research by the Istituto Superiore di Sanità confirms that type I interferon can block the progression of the disease
A new weapon could arrive from Italy in the fight against Covid-19. Type I interferon (IFN), released by plasmacytoid dendritic cells (pDc) at the beginning of coronavirus infection, appears to elicit an immune response in the body that blocks the progression of the disease. The discovery comes from the joint work of a team of researchers (University of San Raffaele in Milan, Polyclinic of Tor Vergata, University of Padua, Metabolic Fitness Association) coordinated by the Istituto Superiore di Sanita ‘(ISS). The study published in Plos Pathogens analyzes precisely the mechanisms of innate immune responses in the pathogenesis of Covid-19.
Read Also
- Celebrities struggling with bipolar disorder May 28, 2022
- The main reasons causing blood clots Jul 16, 2020
- Researchers from Jaén will determine the effectiveness of the Covid vaccine in toilets May 28, 2021
- Plans : those that walk, and our advice to stick to it Jun 18, 2020
- The Scary Reason Healthy People Die After an ER Visit Mar 27, 2021
- Covid, at what point is the production of an all-Italian vaccine? Jul 13, 2021
- I have asthma. How to protect yourself during a pandemic coronavirus? Apr 20, 2020